Skip to content
TDIA

Specialty guide

Psychiatric care continues when the appointment ends.

A Friday message, a refill, a missed monitoring test, or an escalating symptom needs a current plan, an available clinician, and a local next step.

A clinical worktable holds instruments used across medical specialties

A psychiatric visit can end at 4:45 p.m. without ending the work. A patient may send a message about worsening suicidal thoughts, miss a monitoring test, request a controlled refill while traveling, or become unreachable after a medication change. A defensible practice has already decided who sees that signal, what plan they can see, when the level of care changes, and who closes the loop.

This guide treats psychiatry as a continuous care system. Coverage review matters, but it comes after the clinical model is clear.

Design the care that happens between appointments

Start with a patient-level path for messages, refills, labs, collateral information, missed appointments, and urgent changes in symptoms. For each path, identify the primary clinician, backup, current treatment plan, callback method, escalation threshold, documentation location, and closing action.

Do not substitute a generic "call 911" instruction for a plan. A low-risk routine message, a request for same-day assessment, and an imminent emergency need different responses. For risk-sensitive remote care, confirm the patient's current location and callback number, know the local emergency or crisis route, and document what happened if a connection fails. The exact process should fit the patient population and service; telebehavioral care often needs a more detailed local-resource plan than routine follow-up.

Test the plan on a Friday evening: a covering clinician receives a message, the usual psychiatrist is unavailable, and the patient is outside the usual area. Can the covering clinician find the latest assessment, safety plan, medication list, emergency contact, and next action without guessing?

Do not assume that every outpatient psychiatrist can initiate an involuntary evaluation. California's 5150 pathway assigns that authority to specified peace officers and designated professionals or staff; the county and the clinician's actual role matter. A threat to an identifiable person needs a separate, fact-specific escalation and documentation path. Civil Code section 43.92 is a limited duty-to-protect rule, and its trigger and discharge differ from the disclosure permission in the Confidentiality of Medical Information Act.

Prescribing starts with assessment, not checkout

Build a separate medication pathway for every program: indication, assessment, contraindications, monitoring, refill criteria, diversion concerns when relevant, adverse-effect response, and after-hours ownership. California prohibits prescribing, dispensing, or furnishing a dangerous drug without an appropriate prior examination and medical indication. Telehealth or an asynchronous tool can support that examination only when it meets the applicable standard of care.

For Schedule II through IV controlled substances, California's CURES rules generally require a consultation before the first prescription, order, administration, or furnishing and at least every six months while treatment continues, subject to statutory exceptions. Put the actual exception analysis and consultation workflow in the prescribing policy; do not treat a portal refill as an automatic clinical decision.

Federal controlled-substance telemedicine rules are also time-sensitive. The DEA's current temporary extension runs through December 31, 2026 and allows specified remote prescribing pathways subject to federal, state, and DEA requirements. It does not replace California rules or the law where the patient is located. Recheck the federal rule before relying on it.

Telehealth begins where the patient is now

California defines the originating site as the patient's location. Obtain and document the required verbal or written consent before the telehealth course begins. Telehealth does not lower the standard of care or change ordinary confidentiality, record, or professional-responsibility duties. A physician caring for a patient located in California must hold a current California license.

At each encounter, record the patient's present physical location, identity, callback method, and whether remote assessment can safely answer the clinical question. For a patient outside California, verify that jurisdiction's authority pathway before nonemergent care. If urgent symptoms arise before that question is resolved, shift to a local emergency or urgent-care handoff rather than abandoning the patient at a state border.

The clinical record should reconcile the remote assessment, messages, collateral, orders, pharmacy activity, monitoring, and follow-up decision. A platform transcript or automated summary is not a substitute for a clinician-reviewed record. Set a policy for when the practice relies on automated output, who corrects errors, and what version or source belongs in the record. For messages, collateral contacts, safety plans, and vendor access, identify the recipient and purpose before disclosure. Part 2 and California confidentiality rules apply only in their defined circumstances; do not assume every psychiatric record has the same disclosure path.

Give the team exact authority and a shared plan

Titles do not answer who may assess new symptoms, prescribe, interpret a result, change a safety plan, or cover an urgent call. Map the actual work for psychiatrists, NPs, PAs, psychologists, therapists, social workers, nurses, coordinators, and covering clinicians: authority basis, competence, employer or contracting entity, record access, escalation route, and start and end dates.

Where an NP or PA participates, use the applicable California pathway rather than a generic "supervision" label. PA services require the statutory supervision, practice-agreement, and competency framework. Qualifying NPs may practice without standardized procedures only in specified settings and on the statutory conditions. The practice must also decide who owns abnormal results, inbox items, and a patient whose regular clinician is on leave. A shared plan can support care; it cannot leave responsibility unassigned.

If the operation includes a federally assisted substance-use-disorder program, assess whether 42 CFR Part 2 applies to its records and disclosures. Part 2 is not a label for all psychiatric information. It depends on the program and data flow.

Treat interventional psychiatry as distinct service lines

"Interventional psychiatry" is too broad for a patient pathway. Map each service from selection through follow-up.

  • TMS: identify the device, intended use, training, treatment parameters, response assessment, record, and escalation process.
  • ECT: identify the indication, device, anesthetic plan, credentialed team, recovery and discharge process, facility privileges, and post-treatment contact. If anesthesia other than local anesthesia or a peripheral nerve block is used at doses that can risk loss of life-preserving protective reflexes, California's outpatient-surgery setting rules can apply. Do not assume TMS, ECT, and medication services share the same setting requirements.
  • Esketamine: follow the product label and REMS pathway. SPRAVATO is not a generic ketamine workflow; the current program requires administration in a certified health care setting and at least two hours of monitoring for sedation, dissociation, respiratory depression with pulse oximetry, and vital-sign changes.
  • Other ketamine pathways: distinguish drug source, formulation, route, setting, monitoring, emergency capacity, transfer route, and after-hours follow-up. Do not let an umbrella term hide those decisions.

For every service, name the clinician who decides candidacy, the person authorized to perform or monitor treatment, the clinical owner after discharge, and the record that carries the plan forward.

If the practice maintains dangerous-drug stock, add the inventory and disposition rules that apply to that possession model. If it promotes ketamine, TMS, outcomes, or credentials, review the public claim against California's ban on misleading advertising, unjustified expectations, and unsupported scientific claims.

Keep management support separate from clinical judgment

Map the professional practice, MSO or platform, facility, pharmacy, device vendor, and any forensic or utilization-review client. California's corporate-practice guidance requires a California-licensed physician to retain ultimate responsibility for or approval of protected clinical decisions. A nonprofessional company can provide administrative support, but it cannot make the clinical call on diagnosis, referral, treatment, record content, or clinician competence.

For forensic opinions, independent examinations, utilization review, disability work, expert testimony, and medical-director duties, use a separate operation card. Identify the contracting party, jurisdiction, report type, clinical versus nonclinical role, record access, and reporting path. Do not assume the policy for treatment automatically applies to a written opinion.

Use insurance as the final document check

After the care model is real, compare it with the actual application, declarations, definitions, endorsements, exclusions, and contracts. Ask how the issued terms apply to the psychiatrist, professional entity, clinicians and contractors, patient-location territory, telehealth, procedures, call coverage, forensic work, and historical services. A rate class, quote, certificate, or shared brand is not a coverage answer.

Run a weekend drill: a traveling patient requests a controlled refill, a portal message describes escalating risk, a monitoring result is late, and an esketamine patient needs follow-up after the usual clinician leaves. The practice should be able to name the authorized clinician, current record, local care route, next clinical action, and the issued-policy terms and reporting/contact path that govern the event.

San Diego psychiatry rate-manual example

Filed rate rows show historical classifications, not current premium or coverage for an actual practice.

Carrier Filed class Rate at $1M/$3M Manual Filing record
TDC Psychiatry $4,712 2014-10-01 (Ed. 10/14) TDC California Rate Pages Ed. 10/14; CDI filing 14-4043 / DCTR-129531290, approved 2014-08-07
MedPro Class 1B $7,175 2013-08-07 (Ed. 07/01/13) The Medical Protective Company, CA State Rate Pages Section III (SR-CA-III), Edition 07/01/13, Standard Claims-Made Mature tables; CDI filing 13-3635 / SERFF MDPC-129010877, approved 2013-08-07
NORCAL 1005 - Psychiatry $6,564 2015-09-28 (manual 08/01/2015) NORCAL Mutual Insurance Company, California Medical Professional Liability Insurance Underwriting Manual, 08/01/2015 (corrected copy), pp. 7-11; CDI filing 14-7766;14-7767 / SERFF NCMC-129678275, approved 2015-09-28
MIEC Psychiatry (class 2, rel 0.40) $4,324.20 2023-02-01 (Rev 2-1-2023) Medical Insurance Exchange of California, Countrywide Underwriting Manual - HPL (Rev 2-1-2023) with California State Exception Pages; CDI filing 20-4143 / SERFF PERR-132594120, approved 2023-02-07, effective 2023-02-01

The full comparison also lists the policy basis, territory mapping, and carrier notes.

Compare filed rates

Sources